High-dose corticosteroid therapy in COVID-19: the RECOVERY trial - Authors' reply. | Lancet;403(10434): 1339-1340, 2024 Apr 06. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Subject descriptor lookup Advanced Search EVID@Easy

High-dose corticosteroid therapy in COVID-19: the RECOVERY trial - Authors' reply.

Peto, Leon; Basnyat, Buddha; Horby, Peter.

Affiliation

Peto L; Nuffield Department of Population Health, University of Oxford, Oxford OX3 7LF, UK. Electronic address: leon.peto@ndph.ox.ac.uk.
Basnyat B; Patan Academy of Health Sciences, Lalitpur, Nepal.
Horby P; Nuffield Department of Medicine, University of Oxford, Oxford OX3 7LF, UK.

Lancet ; 403(10434): 1339-1340, 2024 Apr 06.

Article in En | MEDLINE | ID: mdl-38582564

Subject(s)

COVID-19; Humans; Adrenal Cortex Hormones/therapeutic use

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: COVID-19 Limits: Humans Language: En Journal: Lancet Year: 2024 Document type: Article Country of publication: United kingdom

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: COVID-19 Limits: Humans Language: En Journal: Lancet Year: 2024 Document type: Article Country of publication: United kingdom